Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes-Reference-Cited by-同舟云学术

Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes

Published:2018-09 Issue:9 Volume:102 Page:1479-1486
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Rickels Michael R.,Stock Peter G.,de Koning Eelco J.P.,Piemonti Lorenzo,Pratschke Johann,Alejandro Rodolfo,Bellin Melena D.,Berney Thierry,Choudhary Pratik,Johnson Paul R.,Kandaswamy Raja,Kay Thomas W.H.,Keymeulen Bart,Kudva Yogish C.,Latres Esther,Langer Robert M.,Lehmann Roger,Ludwig Barbara,Markmann James F.,Marinac Marjana,Odorico Jon S.,Pattou François,Senior Peter A.,Shaw James A.M.,Vantyghem Marie-Christine,White Steven

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference29 articles.

1. Report from IPITA-TTS opinion leaders meeting on the future of β-cell replacement;Bartlett;Transplantation,2016

2. Executive summary of IPITA-TTS opinion leaders report on the future of β-cell replacement;Markmann;Transplantation,2016

3. Standardizing clinically meaningful outcome measures beyond HbA1c for type 1 diabetes: a consensus report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange;Agiostratidou;Diabetes Care,2017

4. Outcome measures for artificial pancreas clinical trials: a consensus report;Maahs;Diabetes Care,2016

5. Glucose concentrations of less than 3.0 mmolL (54 mgdL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes.;Diabetes Care,2017

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological functions and affected signaling pathways by Long Non-Coding RNAs in the immune system;Non-coding RNA Research;2025-02

2. α- or β-Adrenergic blockade does not affect transplanted islet cell responses to hypoglycemia in type 1 diabetes;American Journal of Physiology-Endocrinology and Metabolism;2024-09-01

3. 3D printed VEGF-CPO biomaterial scaffold to promote subcutaneous vascularization and survival of transplanted islets for the treatment of diabetes;International Journal of Biological Macromolecules;2024-06

4. The role of donor hypertension and angiotensin II in the occurrence of early pancreas allograft thrombosis;Frontiers in Immunology;2024-05-17

5. Impact of a Public Health Emergency on Behavior, Stress, Anxiety and Glycemic Control in Patients With Pancreas or Islet Transplantation for Type 1 Diabetes;Transplant International;2024-03-27